Ubiquigent Competitors and Similar CompaniesClear all

Ubiquigent's competitors and similar companies include Genentech, Ipsen, Vertex Pharmaceuticals and Cipla.

	Ubiquigent Ubiquigent is a biotech company providing drug discovery services to the research community.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Ipsen Ipsen is a biopharmaceutical company.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date 2009	Founding Date 1976	Founding Date 1929	Founding Date 1989	Founding Date 1935
Type	Type Private	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Dundee, GB HQ Dundee, GB	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees 713% decrease	Employees 18,077	Employees 5,358	Employees 5,40013% increase	Employees 27,764
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 10.2 b	Valuation ($) 121.4 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €3.7b (FY, 2025)	Revenue (est.) $12b (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €659.1m (FY, 2025)	Cost of goods $1.7b (FY, 2025)	Cost of goods ₹95.5b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €3.3b (FY, 2025)	Gross profit $10.4b (FY, 2025)	Gross profit ₹195b (FY, 2026)
Net income	Net income N/A	Net income N/A	Net income €445.1m (FY, 2025)	Net income N/A	Net income ₹38.7b (FY, 2026)
Operating ⚠
Products	Products N/A	Products N/A	Products N/A	Products 6 (FY, 2022)	Products 1.5 k (FY, 2024)
Funding
Total funding raised	Total funding raised $ 795.1k	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 2.4m	Total funding raised N/A